Interleukin-1 Blockade in Cardiac Sarcoidosis: A Pilot Study

Affiliations

¹ Virginia Commonwealth University (VCU) Pauley Heart Center (J.K., J.H.J., A.L., V.M.D., A.B., K.E., B.W.V.T., W.G.H.), Virginia Commonwealth University, Richmond.
² Cardiovascular Center, University of Michigan, Ann Arbor (T.C., F.B., T.K., K.B., S.L.-P.).
³ Department of Biomedical Engineering (J.H.J.), Virginia Commonwealth University, Richmond.
⁴ Division of Rheumatology, Allergy, and Immunology (H.S.), Virginia Commonwealth University, Richmond.
⁵ Division of Pulmonary and Critical Care (A.S., T.I., K.P., E.G.F.), Virginia Commonwealth University, Richmond.
⁶ Department of Medicine (Cardiology), University of Ottawa Heart Institute, Canada (A.T., R.B., D.B.).
⁷ Department of Pharmacotherapy and Outcomes Science (B.W.V.T.), Virginia Commonwealth University, Richmond.
⁸ Robert M. Berne Cardiovascular Research Center, Charlottesville, VA (A.A.).
⁹ Division of Cardiology, Heart and Vascular Center, University of Virginia, Charlottesville (A.A.).

Jordana Kron et al. Circ Arrhythm Electrophysiol. 2023 May.

. 2023 May;16(5):e011869.

doi: 10.1161/CIRCEP.123.011869. Epub 2023 Apr 24.

¹ Virginia Commonwealth University (VCU) Pauley Heart Center (J.K., J.H.J., A.L., V.M.D., A.B., K.E., B.W.V.T., W.G.H.), Virginia Commonwealth University, Richmond.
² Cardiovascular Center, University of Michigan, Ann Arbor (T.C., F.B., T.K., K.B., S.L.-P.).
³ Department of Biomedical Engineering (J.H.J.), Virginia Commonwealth University, Richmond.
⁴ Division of Rheumatology, Allergy, and Immunology (H.S.), Virginia Commonwealth University, Richmond.
⁵ Division of Pulmonary and Critical Care (A.S., T.I., K.P., E.G.F.), Virginia Commonwealth University, Richmond.
⁶ Department of Medicine (Cardiology), University of Ottawa Heart Institute, Canada (A.T., R.B., D.B.).
⁷ Department of Pharmacotherapy and Outcomes Science (B.W.V.T.), Virginia Commonwealth University, Richmond.
⁸ Robert M. Berne Cardiovascular Research Center, Charlottesville, VA (A.A.).
⁹ Division of Cardiology, Heart and Vascular Center, University of Virginia, Charlottesville (A.A.).

No abstract available

Keywords: biomarkers; inflammasomes; interleukins; pericarditis; sarcoidosis.

Conflict of interest statement

Disclosures Drs Abbate and Van Tassell have served as a consultant to Swedish Orphan Biovitrum in the past. The other authors report no conflicts.

1. Kron J, Crawford T. The cardiac sarcoidosis consortium: elucidating a mysterious disease through collaborative research. Eur Heart J. 2022. - PubMed
1. Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, Judson MA, Kron J, Mehta D, Cosedis Nielsen J, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305–23. - PubMed
1. Kron J, Mauro AG, Bonaventura A, Toldo S, Salloum FN, Ellenbogen KA, Abbate A. Inflammasome Formation in Granulomas in Cardiac Sarcoidosis. Circ Arrhythm Electrophysiol. 2019;12:e007582. - PMC - PubMed
1. Kron J, Crawford T, Mihalick V, Bogun F, Jordan JH, Koelling T, Syed H, Syed A, Iden T, Polly K, et al. Interleukin-1 blockade in cardiac sarcoidosis: study design of the multimodality assessment of granulomas in cardiac sarcoidosis: Anakinra Randomized Trial (MAGiC-ART). J Transl Med. 2021;19:460. - PMC - PubMed
1. Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell BW, Dinarello CA. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease. Circ Res. 2020;126:1260–1280. - PMC - PubMed